Location History:
- MoWaldorf, DE (1988)
- Morfelden-Walldorf, DE (1986 - 1991)
- Morfelden-Walld, DE (1991)
- Soden, DE (2003)
- Bad Soden, DE (1993 - 2013)
Company Filing History:
14 out of 330 
12 out of 260 
8 out of 1,829 
Years Active: 1986-2013
Title: Innovations and Contributions of Ursula Schindler
Introduction
Ursula Schindler, based in Bad Soden, Germany, is a prolific inventor with a remarkable portfolio that includes 36 patents. Her work primarily focuses on advancements in pharmaceutical compounds and methods, reflecting her deep commitment to medical innovation.
Latest Patents
Two of her notable inventions highlight her contribution to the field of medicine. The first patent is titled "Methods for determining sodium-proton-exchanger ligand efficiency." This invention elaborates on methods to assess the in vivo efficiency of sodium-proton-exchanger (NHE) ion channel ligands. The procedure includes various steps such as contacting a cell expressing the NHE ion channel with either plasma from an animal and the ligand or plasma from an animal that has received the ligand. This innovative method aims to correlate the ligand's effect on the cell with its availability in the plasma.
The second patent, "Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them," details compounds effective in treating and preventing diseases like cardiovascular disorders, including hypertension and atherosclerosis. These compounds can modulate the body's production of cyclic guanosine monophosphate (cGMP), which is pivotal in maintaining cardiovascular health. This invention also discusses the preparation and pharmaceutical applications of these compounds, showcasing her versatility as an inventor.
Career Highlights
Ursula Schindler has made significant contributions through her work at leading companies, including Aventis Pharma Deutschland GmbH and Cassella Aktiengesellschaft. Her roles at these organizations have provided her with the opportunity to innovate and develop pharmaceutical solutions that address critical healthcare needs.
Collaborations
Throughout her career, Ursula Schindler has collaborated with distinguished professionals such as Hartmut Strobel and Rudi Beyerle. These partnerships have fostered a creative environment conducive to groundbreaking research and development.
Conclusion
Ursula Schindler stands out as a notable inventor in the pharmaceutical field, with a substantial number of patents that have the potential to enhance medical treatments. Her ongoing contributions signify the importance of innovation in addressing healthcare challenges and advancing therapeutic possibilities.